These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7321973)
1. Oral bioavailability of theophylline from hydroalcoholic and alcohol-free preparations. Sligo JH; Charles BG; Ravenscroft PJ Med J Aust; 1981 Oct; 2(8):410-1. PubMed ID: 7321973 [TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability study of theophylline tablets marketed in Australasia. Charles BG; Ravenscroft PJ; Bochner F Med J Aust; 1980 Sep; 2(5):264-6. PubMed ID: 6893618 [TBL] [Abstract][Full Text] [Related]
3. Bioavailability of theophylline following a rectally administered concentrated aminophylline solution. Mason WD; Lanman RC; Amick EN; Arnold J; March L J Allergy Clin Immunol; 1980 Aug; 66(2):119-22. PubMed ID: 7400475 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses. Schuppan D; Molz KH; Staib AH; Rietbrock N Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238 [TBL] [Abstract][Full Text] [Related]
5. Effect of ethanol on theophylline absorption in humans. Koysooko R; Ellis EF; Levy G J Pharm Sci; 1975 Feb; 64(2):99-301. PubMed ID: 1127605 [TBL] [Abstract][Full Text] [Related]
6. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline. Fixley M; Shen DD; Azarnoff DL Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107 [TBL] [Abstract][Full Text] [Related]
7. Theophylline bioavailability following oral administration of six sustained-release preparations. Spangler DL; Kalof DD; Bloom FL; Wittig HJ Ann Allergy; 1978 Jan; 40(1):6-11. PubMed ID: 623398 [TBL] [Abstract][Full Text] [Related]
8. Absorption properties of two theophylline sustained-release products in smokers. Miller R; Rheeders M S Afr Med J; 1984 Jun; 65(26):1045-8. PubMed ID: 6740419 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis. Valet SB; Schwartz RH; Brooks JG Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982 [TBL] [Abstract][Full Text] [Related]
10. The relation of product formulation to absorption of oral theophylline. Weinberger M; Hendeles L; Bighley L N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577 [TBL] [Abstract][Full Text] [Related]
11. Effect of food and tablet division on the absorption of a sustained-release preparation of theophylline. Shenfield GM; Hudson BJ; Boutagy JS; Munro IA; Vandenberg RA Med J Aust; 1984 Apr; 140(8):477-9. PubMed ID: 6708867 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria. Upton RA; Sansom L; Guentert TW; Powell JR; Thiercelin JF; Shah VP; Coates PE; Riegelman S J Pharmacokinet Biopharm; 1980 Jun; 8(3):229-42. PubMed ID: 7420268 [TBL] [Abstract][Full Text] [Related]